Stockscreener 앱 받기
1.554
2.81%
-0.046
전일 마감가:
$1.60
열려 있는:
$1.63
하루 거래량:
1.04M
Relative Volume:
0.82
시가총액:
$297.13M
수익:
$156.37M
순이익/손실:
$-37.49M
주가수익비율:
-7.40
EPS:
-0.21
순현금흐름:
$-47.77M
1주 성능:
-3.42%
1개월 성능:
+26.42%
6개월 성능:
+12.68%
1년 성능:
-14.56%
1일 변동 폭
$1.54
$1.665
1주일 범위
$1.515
$1.70
52주 변동 폭
$1.12
$2.235
Cerus Corp Stock (CERS) Company Profile
명칭
Cerus Corp
전화
(925) 288-6000
주소
1220 CONCORD AVENUE, CONCORD, CA
CERS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CERS
Cerus Corp
|
1.55 | 306.72M | 156.37M | -37.49M | -47.77M | -0.21 |
|
ABT
Abbott Laboratories
|
131.42 | 230.73B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
94.84 | 141.37B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.15 | 139.39B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.39 | 122.43B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
72.76 | 43.41B | 5.69B | 1.41B | 577.90M | 6.9828 |
Cerus Corp Stock (CERS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-04-12 | 개시 | Craig Hallum | Buy |
| 2023-01-20 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-01-17 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2020-10-08 | 재개 | BTIG Research | Buy |
| 2020-06-16 | 재개 | Cantor Fitzgerald | Overweight |
| 2020-02-26 | 개시 | BTIG Research | Buy |
| 2019-11-13 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2019-08-28 | 개시 | Stifel | Buy |
| 2019-08-23 | 재개 | Stephens | Overweight |
| 2018-01-05 | 재개 | Cantor Fitzgerald | Overweight |
| 2017-12-08 | 재개 | BTIG Research | Neutral |
| 2016-07-07 | 재개 | Cantor Fitzgerald | Buy |
| 2015-12-17 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2014-05-02 | 재확인 | MLV & Co | Buy |
| 2013-04-24 | 재확인 | Cantor Fitzgerald | Buy |
| 2013-03-15 | 재확인 | MLV & Co | Buy |
| 2012-04-17 | 개시 | Cantor Fitzgerald | Buy |
| 2012-02-29 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2011-11-10 | 재확인 | MLV & Co | Buy |
| 2011-06-03 | 개시 | Wedbush | Outperform |
| 2011-03-04 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2010-03-09 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2009-08-26 | 업그레이드 | Avondale | Mkt Perform → Mkt Outperform |
모두보기
Cerus Corp 주식(CERS)의 최신 뉴스
Why Cerus Corporation stock is popular among millennialsEarnings Overview Summary & Accurate Buy Signal Notifications - newser.com
Signal strength of Cerus Corporation stock in tech scannersChart Signals & Consistent Profit Alerts - newser.com
Is Cerus Corporation stock a buy for dividend growthWeekly Gains Summary & High Win Rate Trade Alerts - newser.com
Live market analysis of Cerus CorporationJuly 2025 Rallies & AI Driven Stock Reports - newser.com
Can Cerus Corporation stock hit record highs againWeekly Gains Report & Community Trade Idea Sharing - newser.com
Will a bounce in Cerus Corporation offer an exitQuarterly Market Review & Real-Time Volume Trigger Notifications - newser.com
Wealth Enhancement Advisory Services LLC Acquires 27,092 Shares of Cerus Corporation $CERS - Defense World
What is the fair value estimate for Cerus Corporation (CU2) stock in 20252025 Price Targets & Free Verified High Yield Trade Plans - newser.com
Cerus Corporation stock trend forecastJuly 2025 Levels & Verified Chart Pattern Trade Signals - newser.com
What indicators show strength in Cerus CorporationMarket Trend Review & High Conviction Buy Zone Picks - newser.com
Can a trend reversal in Cerus Corporation lead to recoveryQuarterly Earnings Summary & Community Consensus Stock Picks - newser.com
Visualizing Cerus Corporation stock with heatmapsWeekly Gains Report & Verified Momentum Stock Alerts - newser.com
Weiss Ratings Reaffirms Sell (E+) Rating for Cerus (NASDAQ:CERS) - MarketBeat
What’s the recovery path for long term holders of Cerus CorporationJuly 2025 Weekly Recap & Fast Entry High Yield Stock Tips - newser.com
Cerus Corporation (NASDAQ:CERS) Short Interest Update - MarketBeat
What Fibonacci levels say about Cerus Corporation reboundJuly 2025 Weekly Recap & Low Risk Investment Opportunities - newser.com
Can Cerus Corporation stock sustain market leadershipQuarterly Profit Summary & Short-Term Trading Alerts - newser.com
Cerus (NASDAQ:CERS) Share Price Crosses Above 200 Day Moving Average – What’s Next? - Defense World
Cerus (NASDAQ:CERS) Share Price Crosses Above 200 Day Moving AverageWhat's Next? - MarketBeat
Will Cerus Corporation stock recover after recent drop2025 Fundamental Recap & AI Powered Trade Plan Recommendations - newser.com
What analysts say about Cerus Corporation CU2 stockCup and Handle Formations & Free Stay Ahead With Picks - earlytimes.in
What momentum indicators show for Cerus Corporation stockJuly 2025 Movers & Real-Time Volume Analysis - newser.com
Is Cerus Corporation CU2 a good long term investmentTechnical Analysis Insights & High Profit Investment Ideas - earlytimes.in
Cerus Corporation CU2 Stock Analysis and ForecastAutomated Trading Signals & Best Stocks For Explosive Growth - earlytimes.in
What drives Cerus Corporation stock priceGap Up/Gap Down Analysis & High Return Trading Tips - earlytimes.in
What recovery options are there for Cerus CorporationMarket Trend Summary & Daily Momentum Trading Reports - newser.com
Cerus Corp (CERS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Cerus Corp 주식 (CERS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Jensen Chrystal | Chief Legal Officer |
Mar 14 '25 |
Sale |
1.45 |
30,075 |
43,609 |
783,294 |
| Jensen Chrystal | Chief Legal Officer |
Mar 13 '25 |
Sale |
1.45 |
18,949 |
27,476 |
813,369 |
| Jayaraman Vivek K | Chief Operating Officer |
Mar 14 '25 |
Sale |
1.45 |
46,004 |
66,706 |
1,431,326 |
| Jayaraman Vivek K | Chief Operating Officer |
Mar 13 '25 |
Sale |
1.45 |
29,985 |
43,478 |
1,477,330 |
| Greenman William Mariner | President and CEO |
Mar 14 '25 |
Sale |
1.45 |
122,827 |
178,099 |
4,115,845 |
| Greenman William Mariner | President and CEO |
Mar 13 '25 |
Sale |
1.45 |
71,086 |
103,075 |
4,238,672 |
| Green Kevin Dennis | Chief Financial Officer |
Mar 14 '25 |
Sale |
1.45 |
36,740 |
53,273 |
875,867 |
| Green Kevin Dennis | Chief Financial Officer |
Mar 13 '25 |
Sale |
1.45 |
23,147 |
33,563 |
912,607 |
| Benjamin Richard J | Chief Medical Officer |
Mar 14 '25 |
Sale |
1.45 |
30,075 |
43,609 |
685,775 |
| Benjamin Richard J | Chief Medical Officer |
Mar 13 '25 |
Sale |
1.45 |
18,949 |
27,476 |
715,850 |
0.33%
0.77%
자본화:
|
볼륨(24시간):